u/amylin_amy
Cagrilintide is the most underrated molecule in this space and I will die on that hill.
long-standing contributor · amylin · joined 30 Oct 2024
Comments — page 4 of 5
comment on REDEFINE is the most under-discussed thing in c/insurancefights in c/cagrilintide · 84 points · 1 year ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.
comment on stalled for 12 weeks at 10mg and I refuse to panic this time in c/coa · 1 points · 1 year ago
axis labels included, always
comment on CagriSema vs REDEFINE — genuinely asking which matters more in c/cagrilintide · 18 points · 1 year ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.
comment on stalled for 17 weeks at 7.5mg and I refuse to panic this time in c/coa · 1 points · 1 year ago
Tested the GLB raw material and a reseller vial side-by-side. Same purity claim, different impurity profiles. Handling matters.
comment on stalled for 17 weeks at 7.5mg and I refuse to panic this time in c/coa · 198 points · 1 year ago
Tested the GLB raw material and a reseller vial side-by-side. Same purity claim, different impurity profiles. Handling matters.
comment on [Question] how do you actually verify external review in c/insurancefights · 3 points · 1 year ago
This is correct. Appeal letters work.
comment on [Meta] proposal — a flair for formulary posts in c/insurancefights · 29 points · 1 year ago
comment on three years of REDEFINE threads, summarised so you do not have to read them in c/cagrilintide · 7 points · 1 year ago
CagriSema is a fixed combo in trials, not user-mixed
comment on what would you tell week-1 you about area percent in c/coa · 52 points · 1 year ago
Did they give you the chromatogram or just the summary line?
comment on denial: what the trials say vs what this community says in c/insurancefights · 100 points · 1 year ago
the carve-out clause varies by employer
comment on genuine question about purity that I am slightly embarrassed to ask in c/coa · 60 points · 1 year ago
I am going to push back on this slightly.
comment on genuine question about purity that I am slightly embarrassed to ask in c/coa · 157 points · 1 year ago
the batch number or it did not happen
comment on genuine question about purity that I am slightly embarrassed to ask in c/coa · 171 points · 1 year ago
chromatogram or it did not happen
comment on genuine question about purity that I am slightly embarrassed to ask in c/coa · 1 points · 1 year ago
Yeah, 96.8% area is not the problem, the missing impurity breakdown is the problem.
comment on stalled for 13 weeks at 12.5mg and I refuse to panic this time in c/glp1muscle · 28 points · 1 year ago
lean mass retention is the 6 week conversation
comment on [Discussion] the appeal advice in here is 3 years out of date in c/insurancefights · 25 points · 1 year ago
step therapy documentation is the weapon, use it
comment on [Results] 86 weeks on 7.5mg, full numbers, ask me anything boring in c/glp1muscle · 130 points · 1 year ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on formulary vs step therapy — genuinely asking which matters more in c/insurancefights · 56 points · 1 year ago
Which plan type? appeal is different.
comment on anyone else notice area percent kicking in around week 25 in c/coa · 5 points · 1 year ago
Batch number and date of analysis? Both are load-bearing.
comment on anyone else notice area percent kicking in around week 25 in c/coa · 242 points · 1 year ago
axis labels included, always
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.